Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

JEM Research Institute | Researchclopedia

Back to institutions

JEM Research Institute

Atlantis, Floridafacility

10

Works

303

Citations

12

h-index

Top Research Topics

Parkinson's Disease Mechanisms and Treatments Botulinum Toxin and Related Neurological Disorders Musculoskeletal pain and rehabilitation

Top Researchers

Larry B. Goldstein University of Kentucky

951 works44,189 citationsh-index: 92

Recent Research

Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson’s disease: a phase 2, randomized, double-blind, placebo-controlled study

Harini Sarva,Rajesh Pahwa,et al.

20260 citations

Alzheimer's disease research and treatments

Pain Mechanisms and Treatments

Meta-analysis and systematic reviews

Computational Drug Discovery Methods

Gastrointestinal motility and disorders

Stroke Rehabilitation and Recovery

Attention Deficit Hyperactivity Disorder

Ethics in Clinical Research

Advanced Causal Inference Techniques

Rajesh Pahwa Hebron University

478 works25,989 citationsh-index: 83

Bradford Navia Shriners Hospitals for Children - Erie

137 works12,294 citationsh-index: 54

Carlos Singer University of Miami

271 works10,122 citationsh-index: 50

Stuart Isaacson Baylor College of Medicine

261 works6,991 citationsh-index: 43

Kenneth S. Koblan Sumitomo Dainippon Pharma (United States)

175 works6,467 citationsh-index: 45

Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia

Eric Siemers,Elizabeth E. Evans,et al.

20242 citations

Reducing Pre‐screening Cognitive Assessment Variability to improve Enrollment in clinical trials

20240 citations

Overcoming Recruitment Challenges and Increasing Representation and Diversity of Participation in Early MCI Clinical Trials: The MIND Study Experience

A. Lewandowski,Paul Newhouse,et al.

20230 citations

SEMA4D blocking antibody, pepinemab, is a novel potential treatment for neurodegenerative disease: Clinical proof of concept in Phase 2 HD study supports ongoing clinical development in Phase 1/2 AD study

Terrence L. Fisher,Elizabeth E. Evans,et al.

20233 citations

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT <sub>1A</sub> Agonist, in Patients With Parkinson Disease Psychosis

Stuart Isaacson,Larry B. Goldstein,et al.

202322 citations